Compare Charles River Laboratories Intl. Inc (CRL) vs Lockheed Martin Corporation (LMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Lockheed Martin Corporation — how do they compare? Charles River Laboratories Intl. Inc trades at $299.03 (market cap $14.23B), while Lockheed Martin Corporation trades at $508.28 (market cap $117.22B). The key difference: Lockheed Martin Corporation is far larger — about 8.2× Charles River Laboratories Intl. Inc's market cap, and Lockheed Martin Corporation pays a 2.72% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Lockheed Martin Corporation for 86 Days on average.
| CRL | LMT | |
|---|---|---|
Market Cap | $14.23B | $117.22B |
Volume | 1,176,885 | 1,101,121 |
Sector | Health | Industrials |
52-Week High | $310.77 | $676.70 |
52-Week Low | $149.93 | $439.19 |
Typical Hold Time | 33 Days | 86 Days |
Enterprise Value | $17.06B | $133.96B |
Dividend Yield | — | 2.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $300.53, up 0.08% on the day, with a bullish technical outlook and strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, though it faces profitability challenges with a negative net income margin and ROE. Recent investor day presentations highlighted a strategic plan targeting 5-7% revenue growth and $300 million in savings by 2030, driving positive sentiment.
The outlook is cautiously optimistic, supported by analyst buy ratings and a $305.50 consensus price target, but risks include ongoing margin pressure, volatile non-human primate costs, and a high valuation multiple. Earnings growth and successful execution of the new strategic plan are critical for sustained upside.
Lockheed Martin (LMT) trades at $499.22, down 2.14% over the past day, amid a bearish technical signal. The stock shows strong fundamentals with a P/E of 18.73 and net income margin of 8.16%, though recent quarters saw mixed earnings results. Revenue growth is steady, reaching $75.05B in 2025, and the company maintains a robust dividend history, recently declaring a $3.45 payout. Analyst consensus remains bullish with a $635.33 price target, supported by ongoing defense spending and strategic initiatives like AI integration and Skunk Works innovation.
Outlook for LMT is positive due to solid defense contracts and technological advancements, but risks include fixed-price contract volatility and competitive pressures. The stock offers value with a below-sector P/E and high institutional confidence, though investors should monitor execution on earnings targets and macroeconomic impacts on defense budgets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Lockheed Martin Corporation
Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.
Read more on LMT →
